Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Anti-Cancer Agents in Medicinal Chemistry|December 4, 2014
Recent developments towards podophyllotoxin congeners as potential apoptosis inducersAhmed Kamal, Syed Mohammed Ali Hussaini, M Shaheer MalikApplied Microbiology and Biotechnology|May 5, 2012
Features and technical applications of ω-transaminasesM Shaheer Malik, Eul-Soo Park, Jong-Shik ShinJournal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|February 11, 2009
Efforts towards the development of new antitubercular agents: potential for thiolactomycin based compoundsAhmed Kamal, Shaik Azeeza, M Shaheer Malik, et al.RSC Medicinal Chemistry|January 22, 2021
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agentsM Shaheer Malik, Saleh A Ahmed, Ismail I Althagafi, et al.Mini Reviews in Medicinal Chemistry|April 8, 2010
Search for new and novel chemotherapeutics for the treatment of human malignanciesAhmed Kamal, Shaik Azeeza, E Vijaya Bharathi, et al.Anti-Cancer Agents in Medicinal Chemistry|December 31, 2019
Evaluation of Anticancer and Anti-Mitotic Properties of Quinazoline and Quinazolino-Benzothiadiazine DerivativesThoukhir B Shaik, M Shaheer Malik, Sunitha R Routhu, et al.Bioprocess and Biosystems Engineering|December 29, 2010
Optimization of nitrilase production from Alcaligenes faecalis MTCC 10757 (IICT-A3): effect of inducers on substrate specificityY V D Nageshwar, Gurrala Sheelu, Rekha Rao Shambhu, et al.Bioorganic & Medicinal Chemistry Letters|April 13, 2017
Rational design and synthesis of 2-anilinopyridinyl-benzothiazole Schiff bases as antimitotic agentsThokhir B Shaik, S M Ali Hussaini, V Lakshma Nayak, et al.Reviews on Recent Clinical Trials|April 13, 2026
Immunotherapeutics in Combination with Chemotherapy in Clinical TrialsRahaman Shaik, M Shaheer Malik, Munirah M Al-Rooqi, et al.Medchemcomm|August 16, 2018
Recent advances in combretastatin based derivatives and prodrugs as antimitotic agentsZaki S Seddigi, M Shaheer Malik, A Prasanth Saraswati, et al.Pageof 3